{"title":"辉瑞BNT 162b2疫苗诱导的暴发性心包炎病例研究","authors":"Natalie L. Montarello Cardiologist, MBBS, FRACP , Hao Zheng Wong Intensivist, MBBS, FCICM , Ashlee Jeffries Cardiology Registrar, MBBS , Griffith B. Perkins Researcher in Immunology, BSc(Adv), PhD , Pravin Hissaria Immunologist, MBBS, MD, DM, FRACP, FRCPA , Michael B. Stokes Cardiologist, MBBS, FRACP , Eamon Raith Intensivist, MBBS, MACCP, PhD , Karen Teo Cardiologist, MBBS, FRACP, PhD , Julie Bradley Cardiologist, MBBS FRACP, FCSANZ","doi":"10.1016/j.ccrj.2023.06.005","DOIUrl":null,"url":null,"abstract":"<div><p>The use of mRNA COVID-19 vaccine can on rare occasions cause life-threatening, fulminant myopericarditis. This case report demonstrates previously reported benefit of early use of venoarterial extracorporeal membrane oxygenation mechanical assistance and supports the use of intravenous highly purified immunoglobulin pharmacotherapy to help achieve a good clinical outcome.</p></div>","PeriodicalId":49215,"journal":{"name":"Critical Care and Resuscitation","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study\",\"authors\":\"Natalie L. Montarello Cardiologist, MBBS, FRACP , Hao Zheng Wong Intensivist, MBBS, FCICM , Ashlee Jeffries Cardiology Registrar, MBBS , Griffith B. Perkins Researcher in Immunology, BSc(Adv), PhD , Pravin Hissaria Immunologist, MBBS, MD, DM, FRACP, FRCPA , Michael B. Stokes Cardiologist, MBBS, FRACP , Eamon Raith Intensivist, MBBS, MACCP, PhD , Karen Teo Cardiologist, MBBS, FRACP, PhD , Julie Bradley Cardiologist, MBBS FRACP, FCSANZ\",\"doi\":\"10.1016/j.ccrj.2023.06.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The use of mRNA COVID-19 vaccine can on rare occasions cause life-threatening, fulminant myopericarditis. This case report demonstrates previously reported benefit of early use of venoarterial extracorporeal membrane oxygenation mechanical assistance and supports the use of intravenous highly purified immunoglobulin pharmacotherapy to help achieve a good clinical outcome.</p></div>\",\"PeriodicalId\":49215,\"journal\":{\"name\":\"Critical Care and Resuscitation\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical Care and Resuscitation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1441277223000261\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care and Resuscitation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1441277223000261","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study
The use of mRNA COVID-19 vaccine can on rare occasions cause life-threatening, fulminant myopericarditis. This case report demonstrates previously reported benefit of early use of venoarterial extracorporeal membrane oxygenation mechanical assistance and supports the use of intravenous highly purified immunoglobulin pharmacotherapy to help achieve a good clinical outcome.
期刊介绍:
ritical Care and Resuscitation (CC&R) is the official scientific journal of the College of Intensive Care Medicine (CICM). The Journal is a quarterly publication (ISSN 1441-2772) with original articles of scientific and clinical interest in the specialities of Critical Care, Intensive Care, Anaesthesia, Emergency Medicine and related disciplines.
The Journal is received by all Fellows and trainees, along with an increasing number of subscribers from around the world.
The CC&R Journal currently has an impact factor of 3.3, placing it in 8th position in world critical care journals and in first position in the world outside the USA and Europe.